Qui som
Descripció
Ambrilia Biopharma Inc. (TSX:AMB) is a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases. Ambrilia.s broad pipeline includes proprietary mid to early-stage products and two specialty generics.
Les dades empresarials
No disponible
No disponible
11 - 50 persones
No disponible